S-31-6: current status and future perspectives of elderly hypertension in asia

Because of rapid aging and unhealthy life style in most of Asian countries, non-communicable diseases are increasing gradually and become significant disease burden and socioeconomic burden in Asia. However, the level of hypertension management is not good especially in the young adults. Clinical decision-making for hypertension in the elderly should not depend on chronological age alone. Global risk assessment for individual patients, including comorbidities, frailty, functional status, polypharmacy, cognitive impairment, and variable life expectancy and the risk of orthostatic hypotension should be done for better management of hypertension and outcome. There are many conflicting results and discrepancies on the optimal target BP in elderly hypertensive patients. Asians are different from Caucasians in genetic background, pathophysiology, clinical phenotypes, respond to medication, prognosis and etc. Although there are several hypertension guidelines in Asia, development of hypertension management guidelines for Asians is needed through pooled national cohort data, big health data analysis for precision medicine of hypertension. Hypertension is also good candidate for the digital smart healthcare in the near future.